BiochemProbe — Life Science Research Reagents

hDHODH-IN-8 free base

hDHODH-IN-8 is a potent inhibitor of human dihydroorotate dehydrogenase.

For research use only. Not for human or veterinary use.

Purity >98% Stock Inquire

hDHODH-IN-8 structure

CAS No.: 2757405-31-3

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
100 mg USD 1,685.00 BP-02231-100mg In stock Get quote
250 mg USD 2,080.00 BP-02231-250mg In stock Get quote
500 mg USD 3,880.00 BP-02231-500mg In stock Get quote
1 g Inquire BP-02231-1g In stock Inquire

Need another size or custom synthesis? Request a quote.

Description

hDHODH-IN-8 is a potent inhibitor of human dihydroorotate dehydrogenase (hDHODH). hDHODH-IN-8 has potent antiproliferative activity and excellent aqueous solubility.

Biological activity

hDHODH-IN-8 is a potent inhibitor of human dihydroorotate dehydrogenase (hDHODH) with an IC50 of 16 nM. hDHODH-IN-8 has potent antiproliferative activity and excellent aqueous solubility. hDHODH-IN-8 has the potential for the research of tumor disease, especially lymphoma.

Identifiers

SMILES
FC1=C(NC(/C(C#N)=C(O)/C)=O)C=C(O[C@H](C(F)(F)F)C)C(C(NC2=C(F)C=CC=C2F)=O)=C1
InChIKey
BIDNHWHAWYEYKL-JMZICWNOSA-N

Specifications

MW (average)
487.3519
Formula
C21H15F6N3O4
CAS No.
2757405-31-3
Physical state
Solid
Color
White to yellow
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder -20℃ 3 years; In solvent -20℃ 1 month;

Solubility

Soluble in DMSO 25 mg/mL DMF 10 mg/mL

References

[1]. Li C, et al. Design, Synthesis, and Biological Evaluation of a Novel Series of Teriflunomide Derivatives as Potent Human Dihydroorotate Dehydrogenase Inhibitors for Malignancy Treatment. J Med Chem. 2021;64(24):18175-18192.

Same research area

Search Inflammation/Immunology